MX2014002105A - Ligandos de receptor de estrogeno y metodos de uso de los mismos. - Google Patents

Ligandos de receptor de estrogeno y metodos de uso de los mismos.

Info

Publication number
MX2014002105A
MX2014002105A MX2014002105A MX2014002105A MX2014002105A MX 2014002105 A MX2014002105 A MX 2014002105A MX 2014002105 A MX2014002105 A MX 2014002105A MX 2014002105 A MX2014002105 A MX 2014002105A MX 2014002105 A MX2014002105 A MX 2014002105A
Authority
MX
Mexico
Prior art keywords
compound
another embodiment
prostate cancer
levels
castration
Prior art date
Application number
MX2014002105A
Other languages
English (en)
Spanish (es)
Inventor
Mitchell S Steiner
James Dalton
Christopher C Coss
Original Assignee
Gtx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/215,679 external-priority patent/US9427418B2/en
Application filed by Gtx Inc filed Critical Gtx Inc
Priority claimed from PCT/US2012/052141 external-priority patent/WO2013043304A1/en
Publication of MX2014002105A publication Critical patent/MX2014002105A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
MX2014002105A 2011-08-23 2012-08-23 Ligandos de receptor de estrogeno y metodos de uso de los mismos. MX2014002105A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/215,679 US9427418B2 (en) 2009-02-23 2011-08-23 Estrogen receptor ligands and methods of use thereof
PCT/US2012/052141 WO2013043304A1 (en) 2009-02-23 2012-08-23 Estrogen receptor ligands and methods of use thereof

Publications (1)

Publication Number Publication Date
MX2014002105A true MX2014002105A (es) 2014-09-25

Family

ID=48444651

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014002105A MX2014002105A (es) 2011-08-23 2012-08-23 Ligandos de receptor de estrogeno y metodos de uso de los mismos.

Country Status (10)

Country Link
EP (1) EP2747562A4 (cg-RX-API-DMAC7.html)
JP (1) JP2014524479A (cg-RX-API-DMAC7.html)
KR (1) KR20140064906A (cg-RX-API-DMAC7.html)
CN (1) CN103957706A (cg-RX-API-DMAC7.html)
AU (1) AU2012312902B2 (cg-RX-API-DMAC7.html)
CA (1) CA2845890A1 (cg-RX-API-DMAC7.html)
IL (1) IL231070A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN01959A (cg-RX-API-DMAC7.html)
MX (1) MX2014002105A (cg-RX-API-DMAC7.html)
RU (1) RU2014111060A (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3688008A1 (en) * 2017-09-27 2020-08-05 TargImmune Therapeutics AG Castration resistant prostate cancer
SG11202107712SA (en) * 2019-01-30 2021-08-30 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of metastatic castration-sensitive prostate cancer
US20230174662A1 (en) * 2019-02-01 2023-06-08 Fondazione Per L'istituto Oncologico Di Ricerca (Ior) Methods of treating castrate-resistant prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546451B2 (en) * 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
CA2824517A1 (en) * 2005-11-28 2007-05-31 Gtx, Inc. Nuclear receptor binding agents
US8158828B2 (en) * 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
WO2010096801A1 (en) * 2009-02-23 2010-08-26 Gtx, Inc. Estrogen receptor ligands and methods of use thereof

Also Published As

Publication number Publication date
RU2014111060A (ru) 2015-09-27
EP2747562A4 (en) 2015-05-06
CN103957706A (zh) 2014-07-30
IN2014DN01959A (cg-RX-API-DMAC7.html) 2015-05-15
AU2012312902B2 (en) 2016-03-17
AU2012312902A1 (en) 2013-05-23
JP2014524479A (ja) 2014-09-22
KR20140064906A (ko) 2014-05-28
IL231070A0 (en) 2014-03-31
CA2845890A1 (en) 2013-03-28
EP2747562A1 (en) 2014-07-02

Similar Documents

Publication Publication Date Title
CA2753436C (en) Estrogen receptor ligands and methods of use thereof
US9051267B2 (en) Estrogen receptor ligands and methods of use thereof
US9427418B2 (en) Estrogen receptor ligands and methods of use thereof
US20140187641A1 (en) Estrogen receptor ligands and methods of use thereof
AU2004281708B2 (en) Treating bone-related disorders with selective androgen receptor modulators
US20070265296A1 (en) Nuclear receptor binding agents
US10093613B2 (en) Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US9409856B2 (en) Estrogen receptor ligands and methods of use thereof
CA3173036A1 (en) Selective androgen receptor degrader (sard) ligands and methods of use thereof
US9624161B2 (en) Estrogen receptor ligands and methods of use thereof
AU2012312902B2 (en) Estrogen receptor ligands and methods of use thereof
US20140057985A1 (en) Estrogen receptor ligands and methods of use thereof
US20140057946A1 (en) Estrogen receptor ligands and methods of use thereof
WO2013043304A9 (en) Estrogen receptor ligands and methods of use thereof
AU2010215809B2 (en) Estrogen receptor ligands and methods of use thereof